Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide LAR + Pegvisomant in Acromegaly (PAPE)
NCT02668172Phase 4Unknown
- Sponsor
- Erasmus MC
- Start
- Aug 2015
- Primary completion
- Mar 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pasireotide LAR in acromegaly, sponsored by Erasmus MC. Status: unknown.
02
Drugs
pasireotide LAR
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT02668172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02668172.